As of November 2024 Blueprint Medicines has 60.56M shares outstanding, a increase of 1.54% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 60.56M | 1.54% |
2022 | 59.64M | 1.92% |
2021 | 58.52M | 7.31% |
2020 | 54.53M | - |